Literature DB >> 23467400

Nanoamplifiers synthesized from gadolinium and gold nanocomposites for magnetic resonance imaging.

Xiumei Tian1, Yuanzhi Shao, Haoqiang He, Huan Liu, Yingying Shen, Wenlin Huang, Li Li.   

Abstract

We have synthesized an efficient and highly sensitive nanoamplifier composed of gadolinium-doped silica nanoparticles and gold nanoparticles (AuNPs). Magnetic resonance imaging (MRI) in vitro and in vivo assays revealed enhancement of signal sensitivity, which may be explained by electron transfer between water and gadolinium-doped nanoparticles, apparent in the presence of gold. In vitro and in vivo evaluation demonstrated nanoamplifier incurred minimal cytotoxicity and immunotoxicity, increased stability, and gradual excretion patterns. Tumor targeted properties were preliminarily determined when the nanoamplifier was injected into mouse models of colon cancer liver metastasis. Furthermore, although AuNPs departed from the nanoamplifiers in specific mice tissues, optical and magnetic resonance imaging was efficient, especially in metastatic tumors. These assays validate our nanoamplifier as an effective MRI signal enhancer with sensitive cancer diagnosis potential.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23467400     DOI: 10.1039/c3nr00170a

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  8 in total

1.  Gd2O3-doped silica @ Au nanoparticles for in vitro imaging cancer biomarkers using surface-enhanced Raman scattering.

Authors:  Lifu Xiao; Xiumei Tian; Sitaram Harihar; Qifei Li; Li Li; Danny R Welch; Anhong Zhou
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2017-03-22       Impact factor: 4.098

2.  DNA-gadolinium-gold nanoparticles for in vivo T1 MR imaging of transplanted human neural stem cells.

Authors:  Francesca J Nicholls; Matthew W Rotz; Harmanvir Ghuman; Keith W MacRenaris; Thomas J Meade; Michel Modo
Journal:  Biomaterials       Date:  2015-11-14       Impact factor: 12.479

Review 3.  The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy.

Authors:  L Sancey; F Lux; S Kotb; S Roux; S Dufort; A Bianchi; Y Crémillieux; P Fries; J-L Coll; C Rodriguez-Lafrasse; M Janier; M Dutreix; M Barberi-Heyob; F Boschetti; F Denat; C Louis; E Porcel; S Lacombe; G Le Duc; E Deutsch; J-L Perfettini; A Detappe; C Verry; R Berbeco; K T Butterworth; S J McMahon; K M Prise; P Perriat; O Tillement
Journal:  Br J Radiol       Date:  2014-07-03       Impact factor: 3.039

Review 4.  Gadolinium-based layered double hydroxide and graphene oxide nano-carriers for magnetic resonance imaging and drug delivery.

Authors:  Muhammad Sani Usman; Mohd Zobir Hussein; Sharida Fakurazi; Fathinul Fikri Ahmad Saad
Journal:  Chem Cent J       Date:  2017-05-30       Impact factor: 4.215

Review 5.  Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment.

Authors:  Inés Mármol; Javier Quero; María Jesús Rodríguez-Yoldi; Elena Cerrada
Journal:  Cancers (Basel)       Date:  2019-06-05       Impact factor: 6.639

Review 6.  Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies.

Authors:  Zhengyang Yang; Wei Deng; Xiao Zhang; Yongbo An; Yishan Liu; Hongwei Yao; Zhongtao Zhang
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

7.  High sensitivity of gold nanoparticles co-doped with Gd2O3 mesoporous silica nanocomposite to nasopharyngeal carcinoma cells.

Authors:  Hui Wang; Songjin Zhang; Xiumei Tian; Chufeng Liu; Lei Zhang; Wenyong Hu; Yuanzhi Shao; Li Li
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

8.  Gadolinium-Doped Gallic Acid-Zinc/Aluminium-Layered Double Hydroxide/Gold Theranostic Nanoparticles for a Bimodal Magnetic Resonance Imaging and Drug Delivery System.

Authors:  Muhammad Sani Usman; Mohd Zobir Hussein; Sharida Fakurazi; Mas Jaffri Masarudin; Fathinul Fikri Ahmad Saad
Journal:  Nanomaterials (Basel)       Date:  2017-08-31       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.